Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

PSNL

Personalis (PSNL)

Personalis Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:PSNL
일자시간출처헤드라인심볼기업
2020/02/1909:49Business WirePersonalis, Inc. interverrà alla conferenza Biomarkers Series UK 2020NASDAQ:PSNLPersonalis Inc
2020/02/1906:05Business WirePersonalis, Inc. to Present at Biomarkers Series UK 2020 ConferenceNASDAQ:PSNLPersonalis Inc
2020/02/1822:00Business WirePersonalis to Participate at the Cowen 40th Annual Health Care ConferenceNASDAQ:PSNLPersonalis Inc
2020/02/1507:59Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:PSNLPersonalis Inc
2020/02/1507:40Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PSNLPersonalis Inc
2020/02/1420:17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PSNLPersonalis Inc
2020/02/1208:45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PSNLPersonalis Inc
2020/01/2302:15Business WirePersonalis, Inc. to Present at Precision Medicine World Conference 2020NASDAQ:PSNLPersonalis Inc
2020/01/0807:15Business WirePersonalis, Inc. Announces the Launch of the NeXT Dx™ Test, a Comprehensive Genomic Cancer Profiling Test Enabling Advanced...NASDAQ:PSNLPersonalis Inc
2019/12/2708:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PSNLPersonalis Inc
2019/12/1121:32Business WirePersonalis, Inc. hält Präsentation auf ESMO-Immunonkologie-Kongress 2019NASDAQ:PSNLPersonalis Inc
2019/12/1118:12Business WirePersonalis, Inc. réalisera une présentation lors du Congrès 2019 ESMO de l’immuno-oncologieNASDAQ:PSNLPersonalis Inc
2019/12/1114:48Business WirePersonalis, Inc. interverrà all’edizione 2019 del Congresso di immuno-oncologia della ESMONASDAQ:PSNLPersonalis Inc
2019/12/1110:00Business WirePersonalis, Inc. to Present at ESMO Immuno-Oncology Congress 2019NASDAQ:PSNLPersonalis Inc
2019/12/0608:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PSNLPersonalis Inc
2019/12/0608:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PSNLPersonalis Inc
2019/12/0608:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PSNLPersonalis Inc
2019/11/2608:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PSNLPersonalis Inc
2019/11/2122:00Business WirePersonalis, Inc. to Present at NeoAg Summit US 2019NASDAQ:PSNLPersonalis Inc
2019/11/2008:25Business WirePersonalis, Inc. gibt die Zusammenarbeit mit der Merck KGaA, Darmstadt, Deutschland, zur Identifizierung und Entwicklung neue...NASDAQ:PSNLPersonalis Inc
2019/11/2008:16Business WirePersonalis, Inc. annuncia una collaborazione con Merck KGaA, Darmstadt, Germania per l’identificazione e lo sviluppo di nuo...NASDAQ:PSNLPersonalis Inc
2019/11/2008:12Business WirePersonalis, Inc. annonce sa collaboration avec Merck KGaA, Darmstadt, Allemagne, pour identifier et développer de nouveaux b...NASDAQ:PSNLPersonalis Inc
2019/11/2006:05Business WirePersonalis to Present at Upcoming Investor ConferencesNASDAQ:PSNLPersonalis Inc
2019/11/1922:00Business WirePersonalis, Inc. Announces Collaboration With Merck KGaA, Darmstadt, Germany, to Identify & Develop Novel Biomarkers for Canc...NASDAQ:PSNLPersonalis Inc
2019/11/1806:30Business WirePersonalis, Inc. to Present New Data at the AACR Tumor Immunology and Immunotherapy ConferenceNASDAQ:PSNLPersonalis Inc
2019/11/1406:20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PSNLPersonalis Inc
2019/11/1406:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSNLPersonalis Inc
2019/11/1406:05Business WirePersonalis Reports Third Quarter 2019 Financial ResultsNASDAQ:PSNLPersonalis Inc
2019/11/1307:30Business WirePersonalis, Inc. Expands Oncology Portfolio With the Launch of Cancer Whole Genome Sequencing ServicesNASDAQ:PSNLPersonalis Inc
2019/11/0703:15Business WirePersonalis, Inc. to Present New Data at the Society for Immunotherapy of Cancer (SITC) 34th Annual MeetingNASDAQ:PSNLPersonalis Inc
 검색 관련기사 보기:NASDAQ:PSNL